UCSF

2003 News

Leslie Z. Benet, PhD, was named a Thomson ISI Highly Cited Researcher in December 2003. The designation means that Benet's research publications on pharmacokinetics and pharmacodynamics have been extensively cited by other scientists in their publications. Citation is an important way to measure influence in science through time.
R. William Soller, PhD is the new director of the Center for Consumer Self Care, UCSF School of Pharmacy. The Center supports research on consumer behavior and health policy issues related to prescription and non-prescription medicines and dietary supplements. For more information, see New Leader for Center for Consumer Self Care at UCSF and School of Pharmacy [Center for Consumer Self Care] [link defunct].
The California Poison Control System (CPCS), a unit of the School of Pharmacy, Department of Clinical Pharmacy at the University of California, San Francisco in conjunction with the California's Statewide Area Health Education Center Program (AHEC) has been awarded a US$1.5 million federal grant to help prepare California health professionals to rapidly and effectively respond to bioterrorism and other public health emergencies.
Michael Winter, PharmD, professor of clinical pharmacy, School of Pharmacy, University of California, San Francisco (UCSF) is the California Society of Health-System Pharmacists (CSHP) 2003 Pharmacist of the Year. The award, one of CSHP's highest honors, will be presented on October 24, 2003 during the society's annual meeting in Sacramento, California.
The UCSF School of Pharmacy will establish its first distinguished professorship following a gift from one of its most illustrious alums. Harry Wm. Hind -- inventor of both the Lidoderm® patch and the wetting solution that helped bring contact lenses into widespread use -- and his wife, Diana V. Hind, have given US$2.65 million to establish the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Science.
Koda-Kimble
Reactions to Mission Bay moves. Ideas for generating revenue to offset the California budget deficit. How we gather input and advice to shape our planning. Awards and retirements (Kuntz, McCart, Ruggiero, Sutherland). Relocation of the Office of Student & Curricular Affairs. New School of Medicine Dean David Kessler, MD. Harry W. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences.
Irwin (Tack) D. Kuntz, PhD, professor, Department of Pharmaceutical Chemistry, UCSF School of Pharmacy has been named the 2003 Volwiler Research Achievement Award recipient by the American Association of Colleges of Pharmacy (AACP).
A plan seeded in 1996 by the World Health Organization for an international agreement, [Framework Convention on Tobacco Control] [link defunct]," is undergoing final discussions by member states before submission to the World Health Assembly in May. The plan outlines a global regulatory system aimed at controlling the tobacco pandemic, which, if no action is taken, is expected to claim an estimated 10 million lives by the late 2020s.
UCSF faculty members voted last December 52% to 48% to no longer accept funds from manufacturers of tobacco products or their subsidiaries. Those in favor of the ban argued that UCSF must oppose tobacco industry funding of academia since the health sciences campus is a leader in tobacco control policies and the fight against nicotine addiction and tobacco use prevention. Those opposed to the ban argued that the issue is one of academic freedom in choosing funding sources.
Koda-Kimble
California budget deficit leads to UC cuts and student fee increases. Scientists move in to Mission Bay. 2003 PharmD applications up 32% over 2002. ACPE Accreditation approved. Exit survey and post-graduate survey results. Honors and awards (The Annals of Pharmacotherapy, Kuntz, Pohorille, Nguyen, Whitely).
Tom James, PhD, chair of the department of pharmaceutical chemistry, UCSF School of Pharmacy, is looking for new drug models that act directly on RNA rather than protein, where most drug work is now being done. Why? See UCSF Magazine, "X is for Marking the Spot," August 2002.
The tobacco industry was the silent partner behind a study to refute an influential 1981 Japanese research study about the harmful effects of passive smoke, according to UCSF School of Pharmacy tobacco policy scientist Lisa Bero, PhD and her colleague Mi-Kyung Hong, MPH. For more information, see "How the tobacco industry responded to an influential study of the health effects of secondhand smoke,"
Two studies conducted by UCSF School of Pharmacy researchers demonstrate how follow-up care by pharmacists can help patients adhere to their medications, decrease the number of return visits, and increase patient satisfaction. For more information, see UCSF Magazine, "L is for Listening," August 2002.